At CPHI Frankfurt (28 to 30 October 2025), the Sanner Group will be showcasing its expanded CDMO range for medical technology and drug delivery systems as well as innovations from the pharmaceutical packaging and moisture management segments. The new CEO Stefan Verheyden will be presenting at a trade fair for the first time.
At CPHI, Sanner will be highlighting the company's two strategic pillars: a globally expanded CDMO (Contract Development & Manufacturing Organisation) portfolio for complex delivery systems and medical devices, as well as its many years of expertise in moisture management for pharmaceutical packaging. According to the company, new production capacities have been built up over the past two years and design expertise has been strengthened through the acquisition of the development offices Springboard and Gilero. „Sanner occupies an important market position in the global pharmaceutical packaging industry. With our expanded capacities and a clear vision, we are ready to take on a leading position as a MedTech CDMO,“ says Stefan Verheyden, CEO of the Sanner Group.
CDMO services with an integrated approach
According to the company, the offering comprises end-to-end processes from conception to commercial production - including design for manufacturing and assembly (DFMA), precision engineering and regulatory expertise. The aim is to reduce complexity, time and risk in the transition from development to industrialisation. Sanner also emphasises its global presence with locations in Europe, North America and Asia.
Focus on active packaging and moisture management
On the product side, Sanner will be showcasing the optimised TabTec CR packaging solution for solid oral dosage forms at stand 0J92 in hall 8. The design has been revised and can be combined with customised dry ingredient solutions as part of the Advance with Agility programme. According to the company, a predictive stability approach helps to achieve stability targets faster and accelerate market launches.
Source: Sanner
